Skip to content

Ablelite Pediatric Device Clinical Study

Ablelite Pediatric Device Clinical Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04308447
Enrollment
20
Registered
2020-03-16
Start date
2020-07-01
Completion date
2021-01-31
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscular Dystrophies

Brief summary

The primary objective of the AbleLite early feasibility study is to evaluate the function of the upper limbs of participants diagnosed with neuromuscular disorders as children, with and without use of the Abilitech AbleLite device in the clinic and home environments. Functional outcomes will include documenting active range of motion and the ability to perform activities of daily living (ADLs) using the standardized Canadian Occupational Performance Measure (COPM) and the Role Evaluation of Activities of Life (REAL) assessments. Secondary objectives are to assess the safety record and report on adverse events (AEs) and parameters related to device usage, including device usage time and the time required to don/doff the device.

Interventions

DEVICEAbleLite

The AbleLite device is a passively powered orthotic device designed to support and assist the arms of patients with neuromuscular weakness for activities of daily living.

Sponsors

Gillette Children's Specialty Healthcare
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
AbiliTech Medical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects between 9 and 18 years of age, with pediatric onset of neuromuscular conditions that cause quadriparesis 2. MMT score of 1-3 in the elbow, wrist and hands, and an MMT score of 2- to 3 in the shoulder 3. Ability of subject to raise their forearm off of their lap or laptray 4. Willingness to comply and participate with the study protocol and attend the study sessions 5. Ability to communicate verbally and respond to questions and commands 6. Ability to provide informed consent 7. Selected for participation based on investigator discretion

Exclusion criteria

1. Use of ventilator 2. Open wounds or chronic pressure sores on upper extremities, neck, back or torso 3. Significantly unstable upper extremity joints 4. Unhealed bone fractures in the upper extremities 5. Active rotator cuff tear, grade 2 or 3 6. Surgical fixations limiting full passive range of motion 7. Uncontrolled upper-limb spasticity that significantly limits normal range of motion 8. Uncontrollable pain in the neck, shoulders or upper limbs 9. Ability to fully raise both hands simultaneously above their head with ease 10. Lack passive shoulder abduction of 120 degrees 11. Lack 90 degrees of passive elbow extension 12. Unable to follow instructions 13. Exhibit significant behavioral problems 14. Inability to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Canadian Occupational Performance Measure (COPM)Change from Baseline before device intervention (30 days), and after device intervention (60 days)The Canadian Occupational Performance Measure is an evidence-based outcome measure designed to capture a client's self-perception of performance in everyday living, over time.
Roll Evaluation of Activities of Life (REAL) assessmentChange from Baseline before device intervention (30 days), and after device intervention (60 days)The REAL is an instrument to help professionals assess a child's ability to care for themselves at home, at school and in the community.

Contacts

Primary ContactDirector of Clinical and Product Management
info@abilitechmedical.com833.225.3123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026